Histology and Cytology Market to Reach $19.3 Billion by 2035

Histology and cytology market was valued at $11.2 billion in 2025 and is projected to reach $19.3 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. This growth is largely driven by the rising global burden of cancer and the increasing need for early diagnostic screening. According to the World Health Organization (WHO), cancer caused nearly 10 million casualties in 2022, highlighting the importance of timely diagnosis. Histology and cytology techniques play a critical role in detecting cancer and other diseases at early stages. The growing adoption of these diagnostic methods across hospitals and laboratories is improving patient outcomes. Additionally, advancements in digital pathology and automation are further supporting market expansion.

Browse the full report description of “Histology and Cytology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables & Reagents, and Software & Digital Solutions), By Test Type (Histology and Cytology ), By Application (Oncology, Infectious Diseases, Gynecological Screening, Non-Oncological Diseases), By End-Use Industry (Hospitals, Diagnostic laboratories, and Academic & research institutes), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/histology-and-cytology-market

Innovation Leaders Transforming the Histology and Cytology Market

The key players in the histology and cytology market include Roche Diagnostics, Thermo Fisher Scientific, Abbott, Danaher, and Siemens Healthineers, among others. These companies are driving innovation through advanced digital pathology, AI-enabled image analysis, and automated histology workflows. Their strategies focus on improving diagnostic accuracy, reducing turnaround time, and enabling early disease detection. Increasing investments in precision diagnostics and laboratory automation are further accelerating global market growth.

• In February 2026, Siemens Healthineers expanded its strategic collaboration with Mayo Clinic to advance AI-driven diagnostics and imaging technologies for cancer care. The partnership focuses on enhancing diagnostic accuracy, including improved detection and monitoring of diseases such as prostate cancer through advanced imaging and AI integration. This collaboration supports the broader shift toward precision diagnostics, indirectly strengthening digital pathology and histology-based workflows.
• In February 2026, Leica Biosystems launched the CM1950 Cryostat with DualEcoTec Cooling System to enhance histology workflows. The system enables faster specimen cooling and improved tissue sectioning, reducing processing time and improving diagnostic efficiency in pathology labs.
• In September 2025, Roche collaborated with Labcorp to advance digital pathology capabilities by deploying its FDA-cleared VENTANA DP 600 and DP 200 slide scanners across pathology services. The partnership enables pathologists to analyze high-resolution digital images instead of traditional slides, improving diagnostic efficiency and accuracy. This initiative also supports AI integration in histopathology workflows, enhancing remote diagnostics and addressing the growing demand for advanced pathology solutions.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Product Type
• By Test Type
• By Application
• By End User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Competitive Landscape: Roche Diagnostics, Thermo Fisher Scientific, Abbott, Danaher, and Siemens Healthineers, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Histology and Cytology Market Report Segment

By Product Type

• Instruments
• Consumables & Reagents
• Software & Digital Solutions

By Test Type

• Histology
• Cytology

By Application

• Oncology
• Infectious Diseases
• Gynecological Screening
• Non-Oncological Diseases

By End-Use Industry

• Hospitals
• Diagnostic laboratories
• Academic & research institutes

Global Histology and Cytology Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/histology-and-cytology-market